Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Sirolimus 0.5 mg
DRUG
2 trials
Sponsors
Rare Partners srl Impresa Sociale
, Università degli Studi di Ferrara
Conditions
Beta-Thalassemia
Phase 2
Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients
Completed
NCT03877809
Rare Partners srl Impresa Sociale
Beta-Thalassemia
Start: 2019-06-27
End: 2022-04-30
Updated: 2024-01-23
Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients (THALA-RAP)
NCT04247750
Università degli Studi di Ferrara
Beta-Thalassemia
Start: 2021-04-13
End: 2022-04-30
Target: 45
Updated: 2021-11-12
Related Papers
Co-Induction of ULK-1 and AHSP mRNAs in Erythroid Precursor Cells Isolated From a Sirolimus-Treated β-Thalassemia Patient: A Case Report Study
British Journal of Biomedical Science
2025-06-27
Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin)
Journal of Clinical Medicine
2024-04-24
4 citations
Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus
International Journal of Molecular Sciences
2023-10-10
8 citations
Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study
Hematology Reports
2023-07-12
5613423 TREATMENT OF ERYTHROID PRECURSOR CELLS FROM β-THALASSEMIC PATIENTS WITH ISOXAZOLE DERIVATIVES: POTENT INDUCTION OF FETAL HEMOGLOBIN
HemaSphere
2023-04-01
5613398 A DRUG REPOSITIONING PROJECT FOR Β-THALASSEMIA: SIROLIMUS AND CINCHONA ALKALOIDS
HemaSphere
2023-04-01
Effects of Sirolimus treatment on patients with <scp>β‐Thalassemia</scp>: Lymphocyte immunophenotype and biological activity of memory <scp>CD4</scp><sup>+</sup> and <scp>CD8</scp><sup>+</sup> T cells
Journal of Cellular and Molecular Medicine
2023-01-10
10 citations
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin)
Therapeutic Advances in Hematology
2022-01-01
27 citations